Review of the safety with biologics in inflammatory bowel disease

Review of the safety with biologics in inflammatory bowel disease

Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in our patients, and some others are in different...

Full description

Bibliographic Details
Main Authors:	Andrea Pascual, Raquel Vicente, Eva Sierra, Santiago García-López
Format:	Article
Language:	English
Published:	Publicaciones Permanyer 2022-07-01
Series:	Journal of IMIDs
Subjects:	Inflammatory bowel disease. Biologic. Safety. Side effects.
Online Access:	https://www.journalofimids.com/frame_esp.php?id=21

Similar Items

Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
by: Gustavo Drügg Hahn, et al.
Published: (2022-07-01)

Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review
by: Elham Tabesh, et al.
Published: (2022-08-01)

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
by: Giuseppe Privitera, et al.
Published: (2021-02-01)

Safety profile and side effects of infliximab and adalimumab in inflammatory bowel disease at a referral center in northeastern Brazil
by: Joelma Aurélio de Sousa Santos, et al.
Published: (2024-02-01)

Position statement on the use of biosimilars in inflammatory bowel disease
by: Emanuel Burri, et al.
Published: (2019-12-01)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
by: Aleksandra Kubas, et al.
Published: (2022-05-01)

Biologics and the timing of operative management of pediatric inflammatory bowel disease
by: Tamara Sharf, et al.
Published: (2023-12-01)

The Role of Biologics Agent in the Treatment of Inflammatory Bowel Disease
by: Tri Hapsoro Guno, et al.
Published: (2017-12-01)

Management of infection in patients with inflammatory bowel disease
by: Sahil Khanna
Published: (2021-07-01)

How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
by: Viviana Laredo, et al.
Published: (2022-02-01)

Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment
by: Zakaria Alameddine, et al.
Published: (2023-09-01)

Use of Biologics in Inflammatory Bowel Disease: Combination and Sequential Therapy
by: Putra Nur Hidayat, et al.
Published: (2022-09-01)

The treatment of inflammatory bowel disease with monoclonal antibodies in Asia
by: Yu Chen, et al.
Published: (2023-01-01)

Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study
by: Martina Tallarico, et al.
Published: (2022-11-01)

Dual biological therapy and small molecules in pediatric inflammatory bowel disease
by: Francesca Penagini, et al.
Published: (2023-10-01)

Biologic agents in inflammatory bowel disease – quality of internet website information
by: Rymon Rofaiel, et al.
Published: (2018-01-01)

Addressing pregnancy‐related concerns in women with inflammatory bowel disease: Insights from the patient's perspective
by: Emma K Flanagan, et al.
Published: (2021-01-01)

Relationship between the Biological Clock and Inflammatory Bowel Disease
by: Jonathan Giebfried, et al.
Published: (2023-05-01)

Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project
by: Maria Antonietta Barbieri, et al.
Published: (2022-12-01)

Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
by: Ji Young Chang, et al.
Published: (2021-12-01)

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?
by: Federica Furfaro, et al.
Published: (2021-07-01)

Immune mechanisms in inflammatory bowel disease/ [electronic book]
by: Blumberg, Richard S., et al.
Published: (2006)

Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
by: F. Milo, et al.
Published: (2023-10-01)

Inflammatory bowel disease : an atlas of investigation and management /
by: Orchard, Timothy R. 534319
Published: (2011)

Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients
by: Eduard Brunet Mas, et al.
Published: (2022-02-01)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
by: Akshay Kapoor, et al.
Published: (2021-05-01)

Inflammatory Bowel Disease and Thrombosis
by: Ahmet Tezel, et al.
Published: (2012-05-01)

Angiogenesis and inflammatory bowel disease
by: Azzam Nahla
Published: (2007-01-01)

Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions
by: Lorena Ortega Moreno, et al.
Published: (2021-08-01)

Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
by: Alessandro Massano, et al.
Published: (2023-07-01)

Optimization of cell therapy in patients with inflammatory bowel diseases
by: L B Lazebnik, et al.
Published: (2012-08-01)

The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
by: Larsen L, et al.
Published: (2016-10-01)

Efficacy and safety of erythropoietin in a chronic model of Inflammatory Bowel Disease
by: Inês Silva, et al.
Published: (2022-12-01)

Assessment of quality of life in patients with inflammatory bowel disease
by: Ives Alexandre Yutani Koseki, et al.
Published: (2022-07-01)

Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature
by: Magdalena Wlazło, et al.
Published: (2022-04-01)

Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease
by: David Schöler, et al.
Published: (2022-08-01)

Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
by: Kacper Nijakowski, et al.
Published: (2021-12-01)

Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience
by: Maheeba Abdulla, et al.
Published: (2022-01-01)

Landscape of inflammatory bowel disease in Singapore
by: Daren Low, et al.
Published: (2022-07-01)

Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract
by: Yolanda Ber, et al.
Published: (2021-07-01)